WallStSmart
NXTC

NextCure  Inc

NASDAQ: NXTC · HEALTHCARE · BIOTECHNOLOGY

$9.78
+1.27% today

Updated 2026-06-04

Market cap
$8.42M
P/E ratio
P/S ratio
9.52x
EPS (TTM)
$-16.82
Dividend yield
52W range
$2 – $16
Volume
0.1M

NextCure  Inc (NXTC) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item201720182019202020212022202320242025
Total assets$19.47M$147.63M$356.17M$306.64M$242.39M$184.16M$128.04M$80.86M$50.18M
Cash & equivalents$8.43M$135.17M$34.09M$32.77M$12.34M$26.63M$13.08M$27.73M$25.98M
Current assets$9.42M$135.78M$340.00M$287.98M$227.82M$163.98M$112.72M$71.81M$43.75M
Total liabilities$43.88M$194.57M$34.68M$12.92M$9.00M$16.63M$13.62M$15.39M$15.24M
Current liabilities$3.12M$10.30M$15.04M$10.32M$6.61M$9.13M$6.88M$9.57M$10.57M
Long-term debt$460000.00$73000.00$3.33M$1.81M
Shareholder equity$-24.41M$-46.94M$321.48M$293.72M$233.39M$167.53M$114.42M$65.47M$34.94M
Retained earnings$-24.50M$-47.30M$-81.03M$-117.64M$-187.03M$-261.76M$-324.48M$-380.14M$-435.98M
Accounts receivable$700000.00$800000.00$300000.00$100000.00
Inventory$0.00$0.00$-700000.00
Goodwill$0.00$0.00

Frequently asked questions

How much free cash flow does NXTC generate?

NXTC produced $-49.61M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is NXTC's balance sheet healthy?

NXTC holds $25.98M in cash and equivalents against — in long-term debt, on $34.94M of shareholder equity. That debt is best read against the cash flow the business throws off each year.